Biosystemix Provides Advanced Data Mining And Predictive Modeling As An S2K Program Partner For The Development Of Personalized Medicine Models In Immune Diseases

Biosystemix (www.biosystemix.com) joins S2K (www.s2k.genome.ca) as partner to develop data-driven computational models that predict disease susceptibility and progression, and therapeutic response. Funded by Genome Canada and Genome Quebec, S2K's program, "Functional Genomics, Pharmacogenomics and Proteomics of the Immune Response in Health and Immune Related Disorders," brings leading experts, institutions, and private sector efforts into a significant partnership to advance fundamental scientific understanding of immune dysfunction, and generate intellectual property for effective diagnostic and therapeutic agents including vaccines.

Back to news